Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02568722 · ClinicalTrials.gov registry record · NA
Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)
A NA study, sponsored by Unity Health Toronto.
- Completed
- Registry status
- NA
- Development phase
- 3,019
- Enrollment target
NCT02568722 is a NA study that has completed, run by Unity Health Toronto. The registered enrollment target is 3,019 participants.
The verdict
NCT02568722, a NA study, has completed, sponsored by Unity Health Toronto.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,019 participants
- Enrollment target
Study Summary
The objectives of this trial are to determine whether, in critically ill patients with severe acute kidney injury (AKI), randomization to accelerated initiation of renal replacement therapy (RRT), compared to standard initiation, leads to: 1. Improved survival (primary outcome); and 2. Recovery of kidney function (principal secondary outcome), defined as independence from RRT at 90 days
Interventions
- OTHER Standard RRT initiation
- OTHER Accelerated RRT initiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,019 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02568722
The ClinicalTrials.gov registry entry for NCT02568722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,019 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Unity Health Toronto, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard RRT initiation is the first listed.
NCT02568722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02568722 about?
NCT02568722 is a clinical study titled "Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)". The objectives of this trial are to determine whether, in critically ill patients with severe acute kidney injury (AKI), randomization to accelerated initiation of renal replacement therapy (RRT), compared to standard initiation, leads to: 1. Improved survival (primary outcome); and 2. Recovery of ...
What is the current status of trial NCT02568722?
This trial is currently completed. It is a NA study. The enrollment target is 3,019 participants. The study started on 2015-10. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02568722?
The interventions under investigation include: Standard RRT initiation (OTHER), Accelerated RRT initiation (OTHER).
Who is sponsoring clinical trial NCT02568722?
This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.